Free Trial
→ Nvidia’s Next Big Move Comes on Feb. 26 (From Weiss Ratings) (Ad) Free LSB Stock Alerts

Lakeshore Biopharma (LSB) SEC Filings & 10K Form

Lakeshore Biopharma logo
$2.24 -0.16 (-6.46%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$2.22 -0.03 (-1.34%)
As of 02/21/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Lakeshore Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
12/19/2024
8:28 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
3:10 PM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
7:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:01 PM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
8:16 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
7:40 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
7:59 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2024
3:00 PM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K/A
09/10/2024
7:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:10 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
7:40 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:28 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form NT 20-F
07/05/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:30 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
6:01 AM		LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
6:45 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:30 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
3:16 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/08/2024
7:32 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
04/29/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:03 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:20 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
7:10 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
7:06 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LSB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...
Porter & Company | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...
Altimetry | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
2025 AI Blueprint features Nvidia’s march to $5 trillion
Nvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...
Weiss Ratings | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...
Investors Alley | Sponsored